An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma (Q43723284)
Jump to navigation
Jump to search
scientific article published in June 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma |
scientific article published in June 1998 |
Statements
1 reference
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma (English)
1 reference
Michon JM
1 reference
Hartmann O
1 reference
Bouffet E
1 reference
Meresse V
1 reference
Coze C
1 reference
Rubie H
1 reference
Bordigoni P
1 reference
Cattiaux E
1 reference
Ward N
1 reference
Bernard JL
1 reference
Lemerle J
1 reference
Zucker JM
1 reference
Philip T
1 reference
1 June 1998
1 reference
1 reference
Identifiers
1 reference